Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix

Gynecologic Oncology

Volumn 75, Issue 2, 1999, Pages 242-247

  Magtibay, Paul M ^a   Perrone, Jack F ^a   Stanhope, C Robert ^a   Katzmann, Jerry A ^a   Keeney, Gary L ^a   Li, Hongzhe ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cervical adenocarcinoma; DNA ploidy; Flow cytometry; Proliferative index

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELL PROLIFERATION; DNA DETERMINATION; EARLY CANCER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; UTERINE CERVIX CARCINOMA;

EID: 0032692299     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5573     Document Type: Article

References (31)

1. Berek J S, Castaldo T W, Hacker N F, Petrilli E S, Lagasse L D, Moore J G. Adenocarcinoma of the uterine cervix. Cancer. 48:1981;2734-2741.
2. Rutledge F N, Galakatos A E, Wharton J J, Smith J P. Adenocarcinoma of the uterine cervix. Am J Obstet Gynecol. 122:1975;236-245.
3. Hunt W G, Silverberg S G, Frable W J. Adenocarcinoma of the cervix: histopathologic and clinical features. Am J Obstet Gynecol. 129:1977;304-315.
4. Fu Y S, Regan J W, Hsiu J G, Storaasli J P, Wentz W B. Adenocarcinoma and mixed carcinoma of the uterine cervix I: clinicopathologic study. Cancer. 49:1982;2560-2570.
5. Milsom I, Friberg L G. Primary adenocarcinoma of the uterine cervix: a clinical study. Cancer. 52:1983;942-947.
6. Tamimi H K, Figge D C. Adenocarcinoma of the uterine cervix. Gynecol Oncol. 13:1982;335-344.
7. Kjorstad K E. Adenocarcinoma of the uterine cervix. Gynecol Oncol. 5:1977;219-223.
8. Fuller A F Jr, Elliot N, Kosloff C, Hoskins W J, Lewis J L Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol. 33:1989;34-39.
9. Shingleton H M, Gore H, Bradley D H, Soong S J. Adenocarcinoma of the cervix: 1. Clinical evaluation and pathological features. Am J Obstet Gynecol. 139:1981;799-814.
10. Kilgore L C, Soong S J, Gore H, Shingleton H M, Hatch K D. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol. 31:1988;137-153.
11. Herman C J, McGraw T P, Marder R J, Bauer K D. Recent progress in clinical quantitative cytology. Arch Pathol Lab Med. 111:1987;505-512.
12. Barlogie B, Johnston D A, Smallwood L, Raber M, Maddox A M, Latreille J, Swartzendruber D E, Drewinko B. Prognostic implications of ploidy and proliferative activity in human solid tumors. Cancer Genet Cytogenet. 6:1982;17-28.
13. Merkel D E, Dressler L G, McGuire W L. Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol. 5:1987;1690-1703.
14. Britton L C, Wilson T O, Gaffey T A, Cha S S, Wieand H S, Podratz K C. DNA ploidy in endometrial carcinoma: major objective prognostic factor. Mayo Clin Proc. 65:1990;643-650.
15. Feichter G E, Kuhn W, Czemobillsky B, Muller A, Heep J, Abel U, Haag D, Kaufmann M, Rummel H H, Kubli F, Goerttler K. DNA flow cytometry of ovarian tumors with correlation to histopathology. Int J Gynecol Pathol. 4:1985;336-344.
16. Friedlander M L, Hedley D W, Taylor I W, Russell P. Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res. 44:1984;397-400.
17. Iverson O E. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol. 155:1986;770-776.
18. Moberger B, Auer G, Forsslund G, Moberger G. The prognostic significance of DNA measurements in endometrial carcinoma. Cytometry. 5:1984;430-436.
19. Rodenberg C J, Cornelisse C J, Heintz P A, Hermans J, Fleuren G J. Tumor ploidy as a major prognostic factor in advanced ovarian cancer. Cancer. 59:1987;317-323.
20. Connor J P, Miller D S, Bauer K D, Murad T M, Rademaker A W, Lurain J R. Flow cytometric evaluation of early invasive cervical cancer. Obstet Gynecol. 81:1993;367-371.
21. Davis J R, Aristizabal S, Way D L, Weiner S A, Hicks M J, Hagaman R M. DNA ploidy, grade, and stage in prognosis of uterine cervical cancer. Gynecol Oncol. 32:1989;4-7.
22. Zanetta G M, Katzmann J A, Kenney G L, Kinney W K, Cha S S, Podratz K C. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma. Gynecol Oncol. 46:1992;13-19.
23. Atkin NB Kay R. Prognostic significance of modal DNA value and other factors in malignant tumors, based on 1465 cases. Br J Cancer. 40:1979;210-221.
24. Kaspar H G, Dinh T V, Hanningan E V. Flow cytometry in cervical adenocarcinoma: correlating DNA content analysis with the clinical picture. J Reprod Med. 42:1997;170-172.
25. Leminen A, Paavonen J, Vesterinen E, Forss M, Wahlstrom T, Kulomaa P, Lehtinen M. Deoxyribonucleic acid cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction. Am J Obstet Gynecol. 162:1990;848-853.
26. Fu Y S, Reagan J W, Fu A S, Janiga K E. Adenocarcinoma and mixed carcinoma of the uterine cervix II. Prognostic value of nuclear DNA analysis. Cancer. 49:1982;2571-2577.
27. Hedley D W, Friedlander M L, Taylor I W, Rugg C A, Musgrove E A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 31:1983;1333-1335.
28. Vindeløv L L, Christensen I J, Nissen N I. A detergent-trypsin method for preparation of nuclei for flow cytometric DNA analysis. Cytometry. 3:1983;323-327.
29. Kjorstad KE Bond B. Stage IB adenocarcinoma of the cervix: metastatic potential and patterns of dissemination. Am J Obstet Gynecol. 150:1984;297-299.
30. Lanciano R M, Martz K, Montana G S, Hanks G E. Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study. Cancer. 69:1992;2124-2130.
31. Yu J M, Zhang H, Wang S Q, Maio H Q, Yang L H, Chen Y T, Tian G D. DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma. Cancer. 68:1991;76-78.